Development of monoclonal antibodies against E1 protein of Chikungunya virus
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0013794 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Kun Wen und 16 weiteren Autor:innen. Beteiligte Einrichtung: GuangDong Engineering Technology Research Center of Rapid Detection for Pathogenic Microorganisms, Zhujiang Hospital, Southern Medical University, Gu…. Hauptthemen laut MEDLINE: Chikungunya virus, Chikungunya Fever, Antibodies, Monoclonal, Antibodies, Viral. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Partnership Programme of Enhancing Laboratory Surveillance and Investigation of Emerging Infectious Diseases and Antimicrobial Resistance for the Department of…, Department of Health of the Hong Kong Special Administrative Region Government.
Abstract (Originalsprache)
Chikungunya fever (CF) is a mosquito-borne viral disease caused by Chikungunya virus (CHIKV) that is being increasingly reported in previously non-endemic areas, including Guangdong, China. Despite the low mortality rate associated with CF, some patients may develop chronic joint pain that persists for months or years. Moreover, due to the similarities in symptomatology between CHIKV and other arboviruses, clinical diagnosis without laboratory confirmation is inaccurate. The CHIKV envelope protein E1, critical for viral entry and assembly, is a promising diagnostic and therapeutic target. In this study, we expressed the CHIKV E1 protein in Escherichia coli and developed 16 monoclonal antibodies (mAbs) against E1 to establish an enzyme immunoassay (EIA). The EIA specifically detects CHIKV E1 with no cross-reactivity to other major human-pathogenic arboviruses, including dengue virus (DENV). We evaluated its performance in serum samples of 84 CHIKV-infected patients, with qRT-PCR as the reference standard, and compared it with 93 healthy and 94 DENV-1-infected controls. The assay achieved a sensitivity of 94.05% (95% CI: 87.3–97.3) and a specificity of 98.4% (95% CI: 95.3–99.5). This E1 antigen-based EIA enables rapid and accurate diagnosis of CHIKV infection to facilitate the control of outbreaks of this emerging arbovirus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GuangDong Engineering Technology Research Center of Rapid Detection for Pathogenic Microorganisms, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- Center for Disease Control and Prevention of Guangzhou, Guangdong, People's Republic of China.
- Department of Blood Transfusion, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
- State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong…
- Department of Infectious Diseases and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People's Republic of China.
ORCID-Profile: Xixia Ding
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Partnership Programme of Enhancing Laboratory Surveillance and Investigation of Emerging Infectious Diseases and Antimicrobial Resistance for the Department of…
- Department of Health of the Hong Kong Special Administrative Region Government
Zitieren
APA
Wen, K., Zhou, Z., Xu, P., Di, B., Song, J., Yang, C., Zhan, L., Zhao, C., Xu, M., Cai, J., Yuan, S., To, K. K., Feng, W., Chan, J. F., Zhou, H., Chen, Y., & Ding, X. (2025). Development of monoclonal antibodies against E1 protein of Chikungunya virus. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013794
Vancouver
Wen K, Zhou Z, Xu P, Di B, Song J, Yang C, et al. Development of monoclonal antibodies against E1 protein of Chikungunya virus. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013794
BibTeX
@article{Wen2025,
author = {Wen, Kun and Zhou, Zhihong and Xu, Peipei and Di, Biao and Song, Jialing and Yang, Cuilian and Zhan, Lili and Zhao, Chongquan and Xu, Mei and Cai, Jianpiao and Yuan, Shuofeng and To, Kelvin Kai-Wang and Feng, Wenxi and Chan, Jasper Fuk-Woo and Zhou, Hongwei and Chen, Yue and Ding, Xixia},
title = {Development of monoclonal antibodies against E1 protein of Chikungunya virus},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0013794}
}
EUVIMED